Monophosphates of formycin B and allopurinol riboside: Interactions with leishmanial and mammalian succino-AMP synthetase and GMP reductase☆
-
Add time:09/05/2019 Source:sciencedirect.com
Formycin B 5′-monophosphate (Form B-MP) and allopurinol riboside 5′-monophosphate (HPPR-MP) are isomers of IMP that are metabolically produced when Leishmania spp. are incubated with the antileishmanial agents formycin B and allopurinol or allopurinol riboside. The interactions of Form B-MP with succino-AMP synthetase and GMP reductase from both leishmanial and mammalian sources were compared with the data of earlier studies with HPPR-MP. Both analogs could substitute for IMP as a substrate for succino-AMP synthetase isolated from Leishmania donovani. The V′max values of Form B-MP and HPPR-MP were about 1% of the V′max of IMP. Only Form B-MP (and not HPPR-MP) could serve as an alternative substrate for mammalian succino-AMP synthetase. The V′max of Form B-MP was 40% that of IMP. The corresponding analogs of AMP, ADP and ATP were produced when Formycin B was incubated with mouse L cells. The Formycin A residue was incorporated into the cellular RNA. The amount of Formycin A-TP produced (relative to ATP) in mouse L cells was considerably less than that produced in Leishmania spp. Both Form B-MP and HPPR-MP were inhibitors of partially purified GMP reductase from L. donovani. The binding of Form B-MP and HPPR-MP to human GMP reductase was 40- and 100-fold weaker, respectively, than the binding to leishmanial GMP reductase. Pretreatment of promastigotes of L. donovani with either allopurinol or Formycin B resulted in >95% reduction of the incorporation of the radiolabel from [14C]xanthine into ATP and >80% reduction of the incorporation of the label into GTP. The HPPR-MP and Form B-MP present in these cells may have inhibited the leishmanial succino-AMP synthetase and GMP reductase. The analogs had little or no effect on the pool sizes of ATP and GTP of either mouse L cells or L. donovani.
We also recommend Trading Suppliers and Manufacturers of formycin diphosphate (cas 18389-49-6). Pls Click Website Link as below: cas 18389-49-6 suppliers
Prev:Conformational transitions between Na+-bound and K+-bound forms of (Na+ + K+)-ATPase, studied with formycin nucleotides
Next:A fluorometric-high-performance liquid chromatographic assay procedure for several enzymatic activities using formycin analogs of adenosine 5′-mono, 5′-tri, and cyclic 3′,5′-monophosphate as substrates☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- A fluorometric-high-performance liquid chromatographic assay procedure for several enzymatic activities using formycin analogs of adenosine 5′-mono, 5′-tri, and cyclic 3′,5′-monophosphate as substrates☆09/06/2019
- Conformational transitions between Na+-bound and K+-bound forms of (Na+ + K+)-ATPase, studied with formycin nucleotides09/04/2019
- Formycin A and its N-methyl analogues, specific inhibitors of E. coli purine nucleoside phosphorylase (PNP): induced tautomeric shifts on binding to enzyme, and enzyme→ligand fluorescence resonance energy transfer09/03/2019
- A molecular orbital study of the conformation of formycin09/02/2019
- Elementary steps of the (Na+ + K+)-ATPase mechanism, studied with formycin nucleotides09/01/2019
- Continuous fluorimetric assay of 5′-nucleotidase with formycin 5′-phosphate as substrate, and its application to properties of substrates and inhibitors☆08/31/2019
- The metabolism of formycin B in Leishmaniadonovani08/30/2019
- Studies of the ADP/ATP carrier of mitochondria with fluorescent ADP analogue formycin diphosphate (cas 18389-49-6)08/29/2019


